Class information for:
Level 1: ZOFENOPRIL//INFARCT EXPANSION//ANGIOTENSIN II AT1 RECEPTOR BLOCKADE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1700 2448 34.8 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
132 22818 ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ZOFENOPRIL Author keyword 22 50% 1% 32
2 INFARCT EXPANSION Author keyword 7 39% 1% 13
3 ANGIOTENSIN II AT1 RECEPTOR BLOCKADE Author keyword 6 80% 0% 4
4 WALTER MACKENZIE HLTH SCI 2C243 Address 6 80% 0% 4
5 ACE INHIBITION Author keyword 6 11% 2% 54
6 PERINDOPRIL Author keyword 6 12% 2% 47
7 RAMIPRILAT Author keyword 5 29% 1% 14
8 ANGIOTENSIN CONVERTING ENZYME INHIBITION Author keyword 4 10% 2% 39
9 AUTOCRINE PARACRINE ACTIONS Author keyword 4 75% 0% 3
10 GISSI GRP Address 4 75% 0% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ZOFENOPRIL 22 50% 1% 32 Search ZOFENOPRIL Search ZOFENOPRIL
2 INFARCT EXPANSION 7 39% 1% 13 Search INFARCT+EXPANSION Search INFARCT+EXPANSION
3 ANGIOTENSIN II AT1 RECEPTOR BLOCKADE 6 80% 0% 4 Search ANGIOTENSIN+II+AT1+RECEPTOR+BLOCKADE Search ANGIOTENSIN+II+AT1+RECEPTOR+BLOCKADE
4 ACE INHIBITION 6 11% 2% 54 Search ACE+INHIBITION Search ACE+INHIBITION
5 PERINDOPRIL 6 12% 2% 47 Search PERINDOPRIL Search PERINDOPRIL
6 RAMIPRILAT 5 29% 1% 14 Search RAMIPRILAT Search RAMIPRILAT
7 ANGIOTENSIN CONVERTING ENZYME INHIBITION 4 10% 2% 39 Search ANGIOTENSIN+CONVERTING+ENZYME+INHIBITION Search ANGIOTENSIN+CONVERTING+ENZYME+INHIBITION
8 AUTOCRINE PARACRINE ACTIONS 4 75% 0% 3 Search AUTOCRINE+PARACRINE+ACTIONS Search AUTOCRINE+PARACRINE+ACTIONS
9 LEFT VENTRICLE REMODELING 4 75% 0% 3 Search LEFT+VENTRICLE++REMODELING Search LEFT+VENTRICLE++REMODELING
10 CARDIAC RENIN ANGIOTENSIN SYSTEM 4 40% 0% 8 Search CARDIAC+RENIN+ANGIOTENSIN+SYSTEM Search CARDIAC+RENIN+ANGIOTENSIN+SYSTEM

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CAPTOPRIL 94 14% 25% 603
2 CAPTOPRIL THERAPY 69 65% 3% 66
3 ENALAPRIL 42 12% 14% 334
4 ENLARGEMENT TRIAL 30 64% 1% 29
5 VENTRICULAR ENLARGEMENT TRIAL 21 51% 1% 30
6 RAMIPRILAT 16 54% 1% 21
7 ORAL CAPTOPRIL 14 55% 1% 18
8 EJECTION FRACTIONS 13 30% 2% 38
9 SYSTEM INHIBITION 12 86% 0% 6
10 SIGNAL CASCADE 10 73% 0% 8

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction - A quantitative review of data from randomized clinical trials 2007 97 50 42%
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status 2010 72 132 36%
A systematic review: Effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction 2007 27 26 88%
Meta-analysis: Angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction 2004 98 37 68%
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease 2009 38 68 47%
Angiotensin receptor blockers and risk of myocardial infarction: systematic review 2005 44 38 63%
Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril 2005 42 38 58%
Evolving concept of cardioprotection in myocardial infarction: from SMILE-1 to SMILE-5 2013 2 25 68%
Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study 2012 9 34 38%
The High-Risk Myocardial Infarction Database Initiative 2012 4 3 67%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 WALTER MACKENZIE HLTH SCI 2C243 6 80% 0.2% 4
2 GISSI GRP 4 75% 0.1% 3
3 CENT HOSP ROGALAND 2 44% 0.2% 4
4 RUSCULLEDA FDN CLIN 2 67% 0.1% 2
5 WALTER MACKENZIE HLTH SCI 2C2 43 1 38% 0.1% 3
6 CARDIOLWALTER MACKENZIE HLTH SCI 2C2 43 1 100% 0.1% 2
7 UNIDAD HYPERTENS 1 50% 0.1% 2
8 HOMEOSTAT REGULAT 1 40% 0.1% 2
9 WALTER MACKENZIE HLTH SCI 2C2 1 27% 0.1% 3
10 HLTH SCI ANIM SERV 1 25% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000151330 FLOSEQUINAN//BTS 53 554//FIRST DOSE HYPOTENSION
2 0.0000125353 AMBIENTES EXTREMOS//EPICAPTOPRIL//PAN NEPHROPATHY
3 0.0000097848 SAN ANTONIO CARDIOVASC PROTE//CARDIAC FIBROBLASTS//MISSISSIPPI HEART
4 0.0000097431 CARVEDILOL//BUCINDOLOL//CARVEDILOL ENANTIOMERS
5 0.0000088181 TRANDOLAPRIL//MULTI PHOTON CONTAMINATION//VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY
6 0.0000086265 PATOL VASC NEFROL EXPT//VASC RENAL PATHOL//MED ALFREDO LANARI
7 0.0000083997 ENDOTHELIAL RESPONSES//RADIAL ARTERY DIAMETER//RAPID VENTRICULAR PACING
8 0.0000075811 CANDESARTAN CILEXETIL//ANGIOTENSIN II RECEPTOR ANTAGONIST//LOSARTAN
9 0.0000068001 UNITE PHYSIOL INTEGREE//ANGIOTENSIN II AT1 RECEPTOR ANTAGONIST//PATHOL VASC
10 0.0000063906 CAS 89396 94 1//TA 6366//MOEXIPRIL